[High-dose chemotherapy for solid tumors]. 1998

H G Sayer, and R Kath, and K Höffken
Klinik für Innere Medizin II der Universität, Jena.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

H G Sayer, and R Kath, and K Höffken
March 1995, Cancer treatment reviews,
H G Sayer, and R Kath, and K Höffken
January 1987, Important advances in oncology,
H G Sayer, and R Kath, and K Höffken
February 2002, Critical reviews in oncology/hematology,
H G Sayer, and R Kath, and K Höffken
July 1996, Ugeskrift for laeger,
H G Sayer, and R Kath, and K Höffken
April 1999, Nederlands tijdschrift voor geneeskunde,
H G Sayer, and R Kath, and K Höffken
January 2001, Cancer control : journal of the Moffitt Cancer Center,
H G Sayer, and R Kath, and K Höffken
January 1996, Tumori,
H G Sayer, and R Kath, and K Höffken
February 2010, Pediatric hematology and oncology,
H G Sayer, and R Kath, and K Höffken
June 1999, Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel,
H G Sayer, and R Kath, and K Höffken
October 2007, Seminars in hematology,
Copied contents to your clipboard!